1352 / 1840
Late side effects (
actuarial
)
mild moderate severe Total
bladder
rectosig
2 .1 %
0 .7 %
0 .4 %
3 .2 %
7 .9 %
3 .8 %
0 .4 %
12 .1 %
(Knocke et al. IJROBP 1997
)
small
bowel
vulvo-
vaginal
Total
1 .9 %
1 .4 %
2 .1 %
5 .4 %
7 .2 %
2 .1 %
0 .7 %
10 .0 %
19 .1 %
8 .0 %
3 .6 %
30 .7 %